BRIEF-Arthur J. Gallagher & Co. Acquires Tresidder Insurance Brokers-February 2024-www.financetom.com

BRIEF-Arthur J. Gallagher & Co. Acquires Tresidder Insurance Brokers

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

BRIEF-Arthur J. Gallagher & Co. Acquires Tresidder Insurance Brokers

Apr 1, 2025 2:37 PM

April 1 (Reuters) - Arthur J. Gallagher & Co. ( AJG ):

* ARTHUR J. GALLAGHER & CO. ( AJG ) ACQUIRES TRESIDDER INSURANCE

BROKERS

* ARTHUR J. GALLAGHER & CO. ( AJG ) - TERMS OF THE TRANSACTION NOT

DISCLOSED

Source text:

Further company coverage:

Previous page： Market Chatter: Whistleblower Claims Boeing Supplier Spirit AeroSystems Regularly Shipped Defective Fuselages Next page： KKR Unit Announces Offer to Buy Alps Logistics at $37.05 Per Share

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Market Chatter: Whistleblower Claims Boeing Supplier Spirit AeroSystems Regularly Shipped Defective Fuselages

May 9, 2024

08:09 AM EDT, 05/09/2024 (MT Newswires) -- Santiago Paredes, who worked for Spirit AeroSystems ( SPR ) , regularly found anywhere from 50 to 100, 200 defects on fuselages that were being shipped to Boeing ( BA ) , he told CBS News in an interview broadcast late Wednesday. (Market Chatter news is derived from conversations with market professionals globally....

KKR Unit Announces Offer to Buy Alps Logistics at $37.05 Per Share

May 9, 2024

08:06 AM EDT, 05/09/2024 (MT Newswires) -- KKR & Co ( KKR ) unit Logisteed announced a tender offer for Alps Logistics at 5,774 Japanese yen ($37.05) per share. Price: 99.99, Change: +0.32, Percent Change: +0.32 ...

Oncolytics Biotech Receives German Regulatory Clearance to Evaluate Pelareorep with Modified Folfirinox in Pancreatic Cancer

May 9, 2024

08:08 AM EDT, 05/09/2024 (MT Newswires) -- Oncolytics Biotech ( ONCY ) , a clinical-stage company specializing in immunotherapy for oncology, on Thursday said it will start enrollment for a new GOBLET study pancreatic cancer cohort after receiving German regulatory and ethics approvals. This cohort will evaluate Oncolytic's pelareorep in combination with modified folfirinox (mFOLFIRINOX) with or without the PD-L1...

Royalty Pharma's Q1 Net Income, Revenue Falls

May 9, 2024

08:10 AM EDT, 05/09/2024 (MT Newswires) -- Royalty Pharma ( RPRX ) reported Thursday Q1 net income attributable to the company of $5 million, down from $341 million a year earlier. Analysts' estimates were not readily available for comparison. Total income and other revenue for the quarter ended March 31 were $568 million, down from $684 million a year earlier....